← All Eyenovia, INC filings

Eyenovia, INC 8-K filings

EYEN
Eyenovia, INC
8-K: Eyenovia Reacquires Rights to MicroPine, Bolstering Late-Stage Pipeline
Eyenovia has reacquired the rights to MicroPine, a potential treatment for pediatric progressive myopia, from Bausch + Lomb, strengthening its late-stage drug portfolio.